Subscribe
Commentary
July 30, 2025|News

The Transcontinental Railroad Begins With UP+NS

Written by Bascome Majors, Senior Equity Research Analyst – Industrials, Susquehanna Financial Group
Union Pacific graphic
The Union Pacific+Norfolk Southern merger terms were largely as expected. NS can walk away from UP for an unsolicited better offer ($11/share break fee), but a BNSF-CSX combination is more likely than a Berkshire Hathaway bidding war with UP. The regulatory timeline to 1H27 was also expected, but lack of a voting trust and the right to walk if STB imposes certain conditions favor UP.

With UP’s and NS’s official merger announcement the morning of July 29 and the merger agreement filed that evening, we expand on our pre-deal thoughts, update our NS and UP models for NS’s 2Q and deal-driven changes (e.g. buyback pause) for both, and sharpen our earlier UP+NS merger model for actual deal terms and guidance.

Nuggets From Merger Agreement Filed Post-Close:

  1. Merger agreement ends if no close before 1/28/2028 but automatically extends for STB-driven delays.
  2. No-shop clause but can consider unsolicited proposals for >50% control (requires five-day notice and right to match) until shareholders approve deal.
  3. Termination fee of $2.5 billion goes both ways (UP for regulatory failure, NS for accepting another proposal; $2.5 billion is ~$11 per NS share).
  4. Pro-UP regulatory out if the STB imposes “materially burdensome regulatory condition” (including requiring a voting trust).
  5. Mexican regulator CNA (Comisión Nacional Antimonopolio, National Antitrust Commission, successor to COFECE, Comisión Federal de Competencia Económica, Comisión Federal de Competencia Económic) must approve, but all other regulators customary besides STB.
  6. NS’s material adverse event carve-outs include anything related to UP as the acquirer.
  7. UP’s MAE carve-outs include ability to obtain debt financing.

Deal Terms: NS shareholders will receive one UP common share and $88.82 in cash for each share of NS, implying ~$313/share at the July 29 close and an ~40% premium from the unaffected May 11 price (prior to Vena’s first public pro-consolidation comments). To fund the transaction, UP will issue ~225 million shares with pro-forma UP/NS legacy holder ownership of 73%/27% in the combined company.

Leverage: We estimate UP will need to issue ~$13 billion in new debt to fund the deal in early 2027. At closing, management expects its debt-to-EBITDA ratio to be ~3.3x (pre-synergies), falling to ~2.8x by year 2 post-close (aligning relatively close with our proforma merger modeling).

Synergies: In total, the combined company is estimated to achieve annualized $2.75 billion in EBIT/EBITDA synergies by the end of year 3 post-close: $1.75 billion from revenue and $1 billion of cost synergies. Revenue synergies are expected from truck conversion and new markets unlocked by the combined network, specifically in the “spine” of the U.S. along the Mississippi River and Ohio Valley, where switching inefficiencies limit mid-haul rail market share today. Cost synergies are expected from improved efficiencies (including technology), reduced purchased services and materials, enhanced asset utilization, and SG&A rationalization. UP expects to spend an additional ~$2B in capex to unlock these synergies, flagging technology first but also network investments.

EPS Accretion: The deal is expected to be accretive to EPS (excluding deal intangible amortization) early in year 2, with accretion reaching high-single-digits in year 3 and beyond.

Free Cash Flow: The combined company is expected to generate ~$12 billion in annual free cash flow by year 3 (vs. 2024 combined FCF of $7.3 billion), with both companies now pausing share repurchases but maintaining their dividends during the review period. UP expects to resume repurchases in year 2, growing them to $10 billion+ annually by year 3. As we noted above, network integration could require $2 billion in incremental capex.

Regulatory Steps: Similar to what we forecasted targeting an early 2027 close, UP+NS outlined an ~22-month regulatory timeline, comprised of a formal merger filing in the next six months, followed by an expected 15-month STB review process. Management acknowledged the empty fifth seat at the STB but remains steadfast in its case with regulators.

No Voting Trust: Management is not pursuing a voting trust, so NS will continue to trade separately until the deal is ultimately approved by the STB in early 2027. If denied, the reverse termination fee requires UP to pay NS $ 2.5 billion (~3% of deal value, ~$11 per NS share).

Social Issues: The combined business will be named Union Pacific, headquartered in Omaha (though NS HQ in Atlanta remains a “core location”). Jim Vena will be the CEO of the combined company, but Mark George (NS CEO) and Richard Anderson (NS Chair, former Delta CEO) will be two of the three NS directors joining UP’s board.

UP-NS Merger Model: We’ve adjusted our initial merger model to match actual deal terms (which were heavier in equity than we expected) and guided synergies (which were in line with our expectations), pulling forward synergy benefits and financing burdens into our standalone 2026 estimated forecasts to gut-check management’s accretion and leverage targets. Based on our analysis, if they deliver on mid-term synergies, we believe their outlooks look achievable for EPS accretion, FCF growth, and fairly rapid de-levering.

NS 2Q25 Results and Guidance: Separately, NS reported 2Q25 EPS of $3.29, slightly below our $3.32 and consensus $3.31. NS also updated FY25 guidance, now expecting revenue growth of 2-3% (down from ~3% but in line with our pre-print ~2%) and OR improvement of 100-150bps Y/Y (also down from ~150bps but in line with our pre-print ~120bps). Despite a softer macro, NS noted an incremental $25 million+ (to $175 million+ from $150 million) in cost-control opportunities.

NS Stock Action: We’re cutting our standalone NS 2025 EPS by $0.15 to $12.60 and 2026 by $0.30 to $14.00, primarily on a flow-through of the share repurchase pause. Our NS target price moves to $284 as we shift our valuation framework to anchor to UP’s deal terms ($89 in cash + one UP share, which closed at $224), discounted back from expected 1H27 close to a 12-month price target. We remain Neutral on NS shares.

UP Stock Action: We updated our UP estimates and price target after its earnings report but make incremental adjustments today on flow-through of the share repurchase pause. Our standalone UP 2025 EPS is unchanged at $11.70, but 2026 falls by $0.40 to $13.00. Our UP price target moves to $257 as we capitalize pro-forma synergy/financing-inclusive EPS from our merger model ($14.85) at our pre-deal target P/E (19x), discounting that value back from expected deal close to a 12-month price target. We remain Positive on UP shares.